COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Jilin Zixin Pharmaceutical Co., Ltd. Announcement on the return of raised funds

Page view

The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.

 
Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as “the company”) held the 12th meeting of the 5th Board of Directors on March 19, 2014, and reviewed and approved the “Proposal on Temporarily Replenishing Working Capital with Partial Idle Raised Funds”. ", agree that the company will use the 50 million yuan idle raised funds to temporarily supplement the working capital, the use period is not more than 6 months. For details of the use of some of the idle raised funds to temporarily supplement the working capital, please refer to the “Securities Times”, “China Securities Journal”, “Shanghai Securities News”, “Securities Daily” and www.cninfo.com.cn on March 20, 2014. .cninfo.com.cn) “Announcement of Jilin Zixin Pharmaceutical Co., Ltd. on the temporary replenishment of working capital with some idle raised funds” (2014-020).
 
On September 22, 2014, the company returned all the funds raised from the above-mentioned temporary supplementary liquidity to RMB 50 million. The company has notified the sponsor institution Northeast Securities Co., Ltd. and the sponsor representative of the return of the above raised funds.
 
 
 
Special announcement.
 
 
 
 
 
                            Jilin Zixin Pharmaceutical Co., Ltd.
 
                              Board of Directors
 
                                                                           September 23, 2014